|
Video: What is a Stock Split?
|
|
VBI Vaccines is a biopharmaceutical company. Co. develops vaccine candidates that mimic the natural presentation of viruses. Co.'s pipeline is comprised of vaccine and immunotherapeutic candidates developed by virus-like particle technologies to target two disease areas, infectious disease and oncology. Co.'s prophylactic candidates are 3-antigen Vaccine for the indication of Hepatitis B (HBV), VBI-1501 for the indication of Cytomegalovirus (CMV), VBI-2901 for the indication of Pan-coronavirus, and VBI-2902 for the indication of COVID-19. Co.'s therapeutic candidates are VBI-2601 for the indication of HBV and VBI-1901 for the indication of Glioblastoma plus other CMV-Associated Cancers. According to our VBIV split history records, VBIV has had 2 splits. | |
|
VBIV (VBIV) has 2 splits in our VBIV split history database. The first split for VBIV took place on July 29, 2014. This was a 1 for 5 reverse split, meaning for each 5 shares of VBIV owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 200 share position following the split. VBIV's second split took place on April 12, 2023. This was a 1 for 30 reverse split, meaning for each 30 shares of VBIV owned pre-split, the shareholder now owned 1 share. For example, a 200 share position pre-split, became a 6.66666666666667 share position following the split.
When a company such as VBIV conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the VBIV split history from start to finish, an original position size of 1000 shares would have turned into 6.66666666666667 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into VBIV shares, starting with a $10,000 purchase of VBIV, presented on a split-history-adjusted basis factoring in the complete VBIV split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
10/10/2014 |
|
End date: |
08/07/2024 |
|
Start price/share: |
$78.90 |
|
End price/share: |
$0.07 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.91% |
|
Average Annual Total Return: |
-51.07% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$8.86 |
|
Years: |
9.83 |
|
|
|
Date |
Ratio |
07/29/2014 | 1 for 5 | 04/12/2023 | 1 for 30 |
|
|